Copyright © 2002 by the European Society of Cardiology.
Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome
a Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, Suita, Japan
b Department of Cardiovascular Dynamics, National Cardiovascular Center, Suita, Japan
c Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan
d Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
e Molecular Cardiology, Salvatore Maugeri Foundation, Pavia, Italy
f Department of Pediatrics (Cardiology), Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, U.S.A.
revised October 16, 2001; accepted October 17, 2001
Abstract
Aims Differences in the sensitivity of the genotype of the congenital long QT syndrome to sympathetic stimulation have been suggested. This study compared the influence of sympathetic stimulation on continuous corrected QT (QTc) intervals between LQT1, LQT2 and LQT3 forms of the congenital long QT syndrome.
Methods and Results We recorded a 12-lead electrocardiogram continuously before and after bolus injection (0·1µg.kg1) of epinephrine followed by continuous infusion (0·1µg.kg1 min1) in 12 LQT1, 10 LQT2, 6 LQT3, and 13 control patients. The QT intervals and previous RR intervals of all beats were measured semi-automatically, and the QTc intervals of all beats were calculated by Bazett's method. The dynamic response of the RR interval to epinephrine was no different between the four groups. The QTc was prolonged remarkably (477±42 to 631± 59ms; P<0·0005, % delta prolongation =+32%) as the RR was maximally decreased (at peak of epinephrine), and remained prolonged at steady state conditions of epinephrine (556±56ms; P<0·0005 vs baseline, +17%) in LQT1 patients. Epinephrine also prolonged the QTc dramatically (502±23 to 620±39ms;P <0·0005, +24%) at peak of epinephrine in LQT2 patients, but this shortened to baseline levels at steady state (531±25ms; P=ns vs baseline, +6%). The QTc was much less prolonged at peak of epinephrine in LQT3 (478±44 to 532±41ms; P<0·05, +11%) and controls (394±21 to 456±18ms; P<0·0005, +16%) than in LQT1 and LQT2 patients, and shortened to the baseline levels (LQT3; 466±49ms, 3%, controls; 397±16ms, +1%; P=ns vs baseline) at steady state.
Conclusion Our data suggest that the dynamic response of ventricular repolarization to sympathetic stimulation differs between LQT1, LQT2 and LQT3 syndromes, and may explain why the trigger of cardiac events differs between the genotypes.
Key Words: Action potentials, catecholamines, genetics, long-QT syndrome, nervous system, sympathetic
f1 Correspondence: Dr Wataru Shimizu, Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita, Osaka, 565-8565 Japan.
f2 Dr Wataru Shimizu was supported by Japan Heart Foundation/Pfizer Pharmaceuticals Inc. Grant for Cardiovascular Disease Research, Kanae Foundation, Kato Memorial Bioscience Research Foundation, and Research Grant for Cardiovascular Diseases (11C-1) from the Ministry of Health, Labour and Welfare, Japan.
References
- Schwartz PJ, Periti M, Malliani A. The long QT syndrome. Am Heart J. 1975;89:378390[CrossRef][ISI][Medline]
- Moss AJ, Schwartz PJ, Crampton RS, Locati E, Carleen E. The long QT syndrome: a prospective international study. Circulation. 1985;71:1721
[Abstract/Free Full Text] - Moss AJ, Schwartz PJ, Crampton RS. The long QT syndrome: prospective longitudinal study of 328 families. Circulation. 1991;84:11361144
[Abstract/Free Full Text] - Roden DM, Lazzara R, Rosen MR, Schwartz PJ, Towbin JA, Vincent GM. Multiple mechanisms in the long-QT syndrome: Current knowledge, gaps, and future directions. Circulation. 1996;94:19962012
[Abstract/Free Full Text] - Priori SG, Barhanin J, Hauer RNW. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II. Circulation. 1999;99:518528
[Abstract/Free Full Text] - Abbott GW, Sesti F, Splawski I. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell. 1999;97:175187[CrossRef][ISI][Medline]
- Schwartz PJ, Priori SG, Spazzolini C. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103:8995
[Abstract/Free Full Text] - Moss AJ, Robinson JL, Gessman L. Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol. 1999;84:876879[CrossRef][ISI][Medline]
- Wilde AAM, Jongbloed RJE, Doevendans PA. Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQT2) patients from KVLQT1-related patients (LQT1). J Am Coll Cardiol. 1999;33:327332
[Abstract/Free Full Text] - Zareba W, Moss AJ, Schwartz PJ. Influence of the genotype on the clinical course of the long-QT syndrome. N Engl J Med. 1998;339:960965
[Abstract/Free Full Text] - Shimizu W, Antzelevitch C. Cellular basis for the electrocardiographic features of the LQT1 form of the long QT syndrome: Effects of ß-adrenergic agonists, antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation. 1998;98:23142322
[Abstract/Free Full Text] - Shimizu W, Antzelevitch C. Differential response to beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol. 2000;35:778786
[Abstract/Free Full Text] - Moss AJ, Zareba W, Benhorin J. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation. 1995;92:29292934
[Abstract/Free Full Text] - Davidenko JM, Cohen L, Goodrow R, Antzelevitch C. Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers: Effects of stimulation rate, potassium, and magnesium. Circulation. 1989;79:674686
[Abstract/Free Full Text] - Priori SG, Napolitano C, Cantu F, Brown AM, Schwartz PJ. Differential response to Na+ channel blockade, ß-adrenergic simulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long-QT syndrome. Circ Res. 1996;78:10091015
[Abstract/Free Full Text] - Shimizu W, Ohe T, Kurita T. Early afterdepolarizations induced by isoproterenol in patients with congenital long QT syndrome. Circulation. 1991;84:19151923
[Abstract/Free Full Text] - Shimizu W, Kurita T, Matsuo K. Improvement of repolarization abnormalities by a K+ channel opener in the LQT1 form of congenital long QT syndrome. Circulation. 1998;97:15811588
[Abstract/Free Full Text] - Antzelevitch C, Yan GX, Shimizu W, Burashnikov A. Electrical heterogeneity, the ECG, and cardiac arrhythmias. Zipes DP, Jalife J. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia: W.B. Saunders Co; 1999. p. 222238
- Shimizu W, Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade de pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation. 1997;96:20382047
[Abstract/Free Full Text] - Viswanathan PC, Rudy Y. Cellular arrhythmogenic effects of the congenital and acquired long QT syndrome in the heterogeneous myocardium. Circulation. 2000;101:11921198
[Abstract/Free Full Text] - Schwartz PJ, Priori SG, Locati EH. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate: Implications for gene-specific therapy. Circulation. 1995;92:33813386
[Abstract/Free Full Text] - Stramba-Badiale M, Priori SG, Napolitano C. Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: a key to sudden death during sleep? Ital Heart J. 2000;1:323328[Medline]
This article has been cited by other articles:
![]() |
C. Antzelevitch Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes Europace, September 1, 2007; 9(suppl_4): iv4 - iv15. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ballo, D. Bernabo, and S. A. Faraguti Abnormal QT responses to adenosine in subjects with long-QT syndrome Eur. Heart J., July 2, 2006; 27(14): 1759 - 1760. [Full Text] [PDF] |
||||
![]() |
H. Vyas, J. Hejlik, and M. J. Ackerman Epinephrine QT Stress Testing in the Evaluation of Congenital Long-QT Syndrome: Diagnostic Accuracy of the Paradoxical QT Response Circulation, March 21, 2006; 113(11): 1385 - 1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Viitasalo, L. Oikarinen, H. Swan, K. A. Glatter, H. Vaananen, H. Fodstad, N. Chiamvimonvat, K. Kontula, L. Toivonen, and M. M. Scheinman Ratio of Late to Early T-Wave Peak Amplitude in 24-h Electrocardiographic Recordings as Indicator of Symptom History in Patients With Long-QT Syndrome Types 1 and 2 J. Am. Coll. Cardiol., January 3, 2006; 47(1): 112 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Viitasalo, L. Oikarinen, H. Swan, K. A. Glatter, H. Vaananen, H. Fodstad, N. Chiamvimonvat, K. Kontula, L. Toivonen, and M. M. Scheinman Ratio of Late to Early T-Wave Peak Amplitude in 24-h Electrocardiographic Recordings as Indicator of Symptom History in Patients With Long-QT Syndrome Types 1 and 2 J. Am. Coll. Cardiol., December 13, 2005; (2005) j.jacc.2005.07.068v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Shimizu The long QT syndrome: Therapeutic implications of a genetic diagnosis Cardiovasc Res, August 15, 2005; 67(3): 347 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. ANTZELEVITCH Modulation of Transmural Repolarization Ann. N.Y. Acad. Sci., June 1, 2005; 1047(1): 314 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch Cardiac repolarization. The long and short of it Europace, January 1, 2005; 7(s2): S3 - S9. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Shimizu, T. Noda, H. Takaki, T. Kurita, N. Nagaya, K. Satomi, K. Suyama, N. Aihara, S. Kamakura, K. Sunagawa, et al. Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome J. Am. Coll. Cardiol., February 19, 2003; 41(4): 633 - 642. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch Sympathetic modulation of the long QT syndrome Eur. Heart J., August 2, 2002; 23(16): 1246 - 1252. [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





